- Report
- January 2024
- 129 Pages
United States
€3367EUR$3,800USD£2,922GBP
Apalutamide is a drug used to treat prostate cancer. It is a type of androgen receptor inhibitor, which works by blocking the action of androgens, hormones that can cause prostate cancer cells to grow. Apalutamide is used in combination with other treatments, such as hormone therapy, to slow the growth of prostate cancer. It is approved by the US Food and Drug Administration (FDA) for the treatment of non-metastatic castration-resistant prostate cancer.
Apalutamide is a relatively new drug, and is part of a growing class of prostate cancer treatments. It is one of several drugs that have been developed to target androgen receptors, which are proteins that can cause prostate cancer cells to grow. Other drugs in this class include enzalutamide and abiraterone.
Apalutamide is available in the US and Europe, and is marketed by several pharmaceutical companies. These include Janssen Pharmaceuticals, Astellas Pharma, and Bayer. Show Less Read more